- Home
- Publications
- Publication Search
- Publication Details
Title
Defining and scoring response to IFN-β in multiple sclerosis
Authors
Keywords
-
Journal
Nature Reviews Neurology
Volume 9, Issue 9, Pages 504-512
Publisher
Springer Nature
Online
2013-07-30
DOI
10.1038/nrneurol.2013.146
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical and MRI predictors of response to interferon-beta and glatiramer acetate in relapsing-remitting multiple sclerosis patients
- (2013) M. Romeo et al. EUROPEAN JOURNAL OF NEUROLOGY
- Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial
- (2013) Ralf Gold et al. LANCET
- Natalizumab Therapy for Multiple Sclerosis
- (2013) Jeremy Chataway et al. Neurotherapeutics
- Predictors of long-term outcome in multiple sclerosis patients treated with interferon beta
- (2012) Robert A. Bermel et al. ANNALS OF NEUROLOGY
- Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial
- (2012) Jeffrey A Cohen et al. LANCET
- Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
- (2012) Alasdair J Coles et al. LANCET
- Scoring treatment response in patients with relapsing multiple sclerosis
- (2012) MP Sormani et al. Multiple Sclerosis Journal
- Serum IL-17F does not predict poor response to IM IFN -1a in relapsing-remitting MS
- (2012) S. E. Bushnell et al. NEUROLOGY
- Fingolimod and multiple sclerosis: Four cautionary tales
- (2012) D. Bourdette et al. NEUROLOGY
- Tumefactive multiple sclerosis lesions under fingolimod treatment
- (2012) F. Visser et al. NEUROLOGY
- The New Era of Multiple Sclerosis Therapeutics
- (2012) Rohit Bakshi Neurotherapeutics
- Interferon Beta and Glatiramer Acetate Therapy
- (2012) Corey A. McGraw et al. Neurotherapeutics
- Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis
- (2012) Giancarlo Comi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
- (2012) Robert J. Fox et al. NEW ENGLAND JOURNAL OF MEDICINE
- Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
- (2012) Ralf Gold et al. NEW ENGLAND JOURNAL OF MEDICINE
- Volumetric MRI Markers and Predictors of Disease Activity in Early Multiple Sclerosis: A Longitudinal Cohort Study
- (2012) Tomas Kalincik et al. PLoS One
- Current and emerging therapies in multiple sclerosis: a systematic review
- (2012) Wanda Castro-Borrero et al. Therapeutic Advances in Neurological Disorders
- Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon β-1b trial in multiple sclerosis
- (2011) Douglas S Goodin et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Comparison of two dosing frequencies of subcutaneous interferon beta-1a in patients with a first clinical demyelinating event suggestive of multiple sclerosis (REFLEX): a phase 3 randomised controlled trial
- (2011) Giancarlo Comi et al. LANCET NEUROLOGY
- Clinical consequences of MRI activity in treated multiple sclerosis
- (2011) Diego Cadavid et al. Multiple Sclerosis Journal
- MRI monitoring of immunomodulation in relapse-onset multiple sclerosis trials
- (2011) Frederik Barkhof et al. Nature Reviews Neurology
- Determinants of interferon β efficacy in patients with multiple sclerosis
- (2011) Joep Killestein et al. Nature Reviews Neurology
- Combined MRI lesions and relapses as a surrogate for disability in multiple sclerosis
- (2011) M. P. Sormani et al. NEUROLOGY
- Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis
- (2011) Paul O'Connor et al. NEW ENGLAND JOURNAL OF MEDICINE
- Magnetic resonance active lesions as individual-level surrogate for relapses in multiple sclerosis
- (2010) Maria Pia Sormani et al. Multiple Sclerosis Journal
- Assessing changes in relapse rates in multiple sclerosis
- (2010) Seidu Inusah et al. Multiple Sclerosis Journal
- T helper type 1 and 17 cells determine efficacy of interferon-β in multiple sclerosis and experimental encephalomyelitis
- (2010) Robert C Axtell et al. NATURE MEDICINE
- A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
- (2010) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
- (2010) Jeffrey A. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Recognizing and treating suboptimally controlled multiple sclerosis: steps toward regaining command
- (2009) Mark S. Freedman et al. CURRENT MEDICAL RESEARCH AND OPINION
- One-year MRI scan predicts clinical response to interferon beta in multiple sclerosis
- (2009) L. Prosperini et al. EUROPEAN JOURNAL OF NEUROLOGY
- Efficacy of intramuscular interferon beta-1a in patients with clinically isolated syndrome: analysis of subgroups based on new risk criteria
- (2009) P O’Connor et al. Multiple Sclerosis Journal
- Imaging outcomes for neuroprotection and repair in multiple sclerosis trials
- (2009) Frederik Barkhof et al. Nature Reviews Neurology
- Predicting responders to therapies for multiple sclerosis
- (2009) Jordi Río et al. Nature Reviews Neurology
- Canadian treatment optimization recommendations (TOR) as a predictor of disease breakthrough in patients with multiple sclerosis treated with interferon β-1a: analysis of the PRISMS study
- (2008) MS Freedman et al. Multiple Sclerosis Journal
- Relationship between MRI lesion activity and response to IFN-β in relapsing–remitting multiple sclerosis patients
- (2008) J Río et al. Multiple Sclerosis Journal
- Clinical Parameters to Predict Response to Interferon in Relapsing Multiple Sclerosis
- (2008) A. Fromont et al. NEUROEPIDEMIOLOGY
- Pharmacogenomics of Interferon-ß Therapy in Multiple Sclerosis: Baseline IFN Signature Determines Pharmacological Differences between Patients
- (2008) Lisa G. M. van Baarsen et al. PLoS One
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now